Cowen and Company’s Bio-Techne TECH Stock Holding History

Cowen and Company’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,456	Closed	-$1.84M	–	691
2021 Q1	$1.67M	Buy	+17,456	New	+$1.59M	0.11%	95

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Cowen and Company's TECH Position: Q2 2021 in Review

Cowen and Company sold out of Bio-Techne (TECH) in Q2 2021, closing a stake of 17,456 shares — an estimated $1.84M sold.

Cowen and Company first reported a position in TECH in Q1 2021 and held it in 1 quarter. The position peaked at $1.67M in Q1 2021. 511 funds tracked by Wall St. Rank hold TECH as of Q2 2021.

Cowen and Company reported no remaining Bio-Techne position as of Q2 2021 after selling out during the quarter.
Cowen and Company sold 17,456 Bio-Techne shares in Q2 2021, an estimated $1.84M.
Cowen and Company first reported a position in Bio-Techne in Q1 2021 and held it in 1 quarter.
Cowen and Company's Bio-Techne position peaked at $1.67M in Q1 2021.
511 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2021.

Based on Cowen and Company's 13F filing for Q2 2021, filed 13 Aug 2021.